Patient responses to atogepant 60 mg once daily: A post hoc analysis of the ADVANCE trial

Authors
Category Primary study
Conference17th European Headache Congress (EHC)
Year 2024
This article has no abstract
Epistemonikos ID: 5f46ad8716622a70b4983611e617dc2c34ec1aa1
First added on: Jan 31, 2026